Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06652568 · ClinicalTrials.gov registry record · NA
Determining the Validity of ThinkSono Guidance for Ultrasound Image Acquisition and Remote Detection
A NA study of Deep Vein Thrombosis and Deep Vein Thrombosis, Pulmonary Embolus, sponsored by ThinkSono.
- Recruiting
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 5
- Study locations
NCT06652568 is a NA study of Deep Vein Thrombosis and Deep Vein Thrombosis, Pulmonary Embolus that is actively recruiting participants, run by ThinkSono. The registered enrollment target is 500 participants, below the 7,911-participant average among 24 other Deep Vein Thrombosis trials with a reported enrollment target (94% lower). The trial reports 5 study locations across 4 states.
The verdict
NCT06652568, a NA study of Deep Vein Thrombosis and Deep Vein Thrombosis, Pulmonary Embolus, is actively recruiting participants, sponsored by ThinkSono.
- RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this study is to confirm the safety and efficacy of the ThinkSono Guidance System, a software data collection and communication tool designed to collect ultrasound data to help detect blood clots in veins. The ThinkSono system is CE Mark approved in the European Union and in clinical use in Europe. Usually, when an ultrasound is conducted to diagnose blood clots in veins, a sonographer (trained technologist who conducts ultrasounds) and/or radiologist will conduct the procedure, including a compression ultrasound exam, and the scan may require a bulky cart and ultrasound equipment. The ThinkSono Guidance System is a mobile software application that enables other healthcare professionals such as nurses, non-radiologist physicians including general practitioners, and other allied healthcare professionals to perform the ultrasound at the point of care using guidance from the software app. This is a multi-site non-randomized, double-blinded, prospective cohort pivotal study.
Conditions Studied
Interventions
- DEVICE ThinkSono System
Study Locations (5)
Pennsylvania
- Temple Health - Philadelphia
- Allegheny Health Network - Pittsburgh
New York
- NYU Langone Health - New York
Texas
- South Texas Veterans Health System - San Antonio
Wisconsin
- University of Wisconsin-Madison - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2023-11-08 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06652568
The ClinicalTrials.gov registry entry for NCT06652568 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,911-participant average among 24 other Deep Vein Thrombosis trials with a reported enrollment target (94% lower). The listed sponsor is ThinkSono, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Deep Vein Thrombosis appearing as the primary indexed condition, and to 1 intervention - of which ThinkSono System is the first listed.
NCT06652568 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Pennsylvania, New York, Texas.
Frequently Asked Questions
What is clinical trial NCT06652568 about?
NCT06652568 is a clinical study titled "Determining the Validity of ThinkSono Guidance for Ultrasound Image Acquisition and Remote Detection". The purpose of this study is to confirm the safety and efficacy of the ThinkSono Guidance System, a software data collection and communication tool designed to collect ultrasound data to help detect blood clots in veins. The ThinkSono system is CE Mark approved in the European Union and in clinical ...
What is the current status of trial NCT06652568?
This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2023-11-08. Estimated completion is 2025-12-31.
What conditions does trial NCT06652568 study?
This clinical trial studies the following conditions: Deep Vein Thrombosis, Deep Vein Thrombosis, Pulmonary Embolus.
What interventions are being tested in trial NCT06652568?
The interventions under investigation include: ThinkSono System (DEVICE).
Who is sponsoring clinical trial NCT06652568?
This trial is sponsored by ThinkSono, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06652568 being conducted?
This trial has 5 study locations across New York, Pennsylvania, Texas, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Deep Vein Thrombosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
RECRUITING · NA
-
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
RECRUITING · NA
-
BOLT: Study of the Indigo® Aspiration System When Used in Patients With Deep Vein Thrombosis
ACTIVE NOT RECRUITING · NA
-
Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial)
ACTIVE NOT RECRUITING · NA
-
Multimodal DVT Protocol in Tourniquet-less Total Knee Arthroplasty
COMPLETED · NA
-
Study to Develop a Reliable Nomogram That Incorporates Clinical and Genetic Information
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.